| GTO ID | GTC1614 |
| Trial ID | NCT02792114 |
| Disease | HER2-Receptor Negative Breast Cancer | Breast Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | T-Cell Therapy for Advanced Breast Cancer |
| Year | 2016 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 16-040 |
| Cohort 1 | |||||||||
|
|||||||||